PharmaNordic ApS: Financial statements 2024
CVR: 36408464
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 593,730 and a net result of DKK 647,775 compared with DKK 515,361 the year before. That is a decrease of 17.8% compared with the year before. Equity in the 2024 report amounted to DKK 1,836,319. The solvency ratio was 81.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 593,730
- Profit/Loss
- DKK 647,775
- Equity
- DKK 1,836,319
- Total Assets
- DKK 2,261,541
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 594 t. | 648 t. | 1.8 mio. | 1 |
| 2023 | - | 723 t. | 515 t. | 1.2 mio. | 1 |
| 2022 | - | 575 t. | 183 t. | 673 t. | 1 |
| 2021 | - | 738 t. | 144 t. | 490 t. | - |
| 2020 | - | 517 t. | 574 t. | 346 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PharmaNordic ApS has published its annual report for 2023. Gross profit came to DKK 722,696, and the net result was DKK 515,361.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.